Biolyticsは、AIを活用して臨床検査結果をデジタル化し、一元管理するモバイルアプリです。OCRやQRコードを使って紙のレポートから簡単にデータを取り込み、直感的なグラフでバイオマーカーの推移を追跡し、分かりやすい説明で健康状態を深く理解できます。データはデバイス上に安全に保存され、完全なプライバシーを確保します。
Data Analyzerは、即座のデータ視覚化と探索のために設計された直感的なAI搭載ツールです。ユーザーはCSV、JSON、Excelなどの様々なデータファイル形式をアップロードし、視覚的な洞察を素早く得て、グローバルな統計、トレンド、データパターンを理解できます。大規模なデータセットの処理に最適化されており、複雑なデータ分析をアクセスしやすく効率的にします。
製品概要
Biolytics 製品概要
Biolyticsは、AIを活用して臨床検査結果をデジタル化し、一元管理するモバイルアプリです。OCRやQRコードを使って紙のレポートから簡単にデータを取り込み、直感的なグラフでバイオマーカーの推移を追跡し、分かりやすい説明で健康状態を深く理解できます。データはデバイス上に安全に保存され、完全なプライバシーを確保します。
Data Analyzer 製品概要
Data Analyzerは、即座のデータ視覚化と探索のために設計された直感的なAI搭載ツールです。ユーザーはCSV、JSON、Excelなどの様々なデータファイル形式をアップロードし、視覚的な洞察を素早く得て、グローバルな統計、トレンド、データパターンを理解できます。大規模なデータセットの処理に最適化されており、複雑なデータ分析をアクセスしやすく効率的にします。
Detailed feature comparison
| Feature | Biolytics | Data Analyzer |
|---|---|---|
| 主要カテゴリー | 医療 | 視覚化 |
| 追加日 | 2025-08-10 | 2025-10-30 |
| 価格 | 無料 | 未確認 |
| 公式サイト | biolytics.app | datainfolab.tech |
| 製品タイプ | アプリ | ウェブサイト |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 1.9K | 3.5K |
| 月間成長率 | 27.4% | 未確認 |
| お気に入り | 115 | 110 |
| Details | 詳細を見る | 詳細を見る |
Biolytics vs Data Analyzer monthly traffic
Compare Biolytics and Data Analyzer by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Biolytics vs Data Analyzer monthly traffic comparison, Biolytics currently shows 1.9K visits and Data Analyzer shows 3.5K; Data Analyzer has about 1.9 times the visible traffic of Biolytics, an absolute difference of about 1.7K visits. This reflects visible reach, not feature quality or paid users.
Only Biolytics has complete third-party traffic details; Data Analyzer uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Biolytics monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 892 月間訪問数
- 2026/1: 712 月間訪問数
- 2026/2: 560 月間訪問数
- 2026/3: 761 月間訪問数
- 2026/4: 1.5K 月間訪問数
- 2026/5: 1.9K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 77.38% | 1.4K |
| 🇩🇪Germany | 12.16% | 227 |
| 🇲🇽Mexico | 6.22% | 116 |
| 🇦🇹Austria | 2.76% | 51 |
| 🇨🇴Colombia | 1.48% | 28 |
検索キーワード
Data Analyzer monthly traffic:
Latest traffic
Usage comparison
Compare the core capabilities of Biolytics and Data Analyzer
Biolytics Core features
Data Analyzer Core features
Use cases
Biolytics Use cases
Data Analyzer Use cases
Best suited roles
Biolytics Best suited roles
Data Analyzer Best suited roles
Biolytics vs Data Analyzer:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Biolytics vs Data Analyzer comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Biolytics is primarily listed under “医療”, while Data Analyzer is primarily listed under “視覚化”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Biolytics: 医療; Data Analyzer: 視覚化); Product type (Biolytics: App; Data Analyzer: Website); Pricing (Biolytics: Free; Data Analyzer: Not disclosed); Monthly visits (Biolytics: 1.9K; Data Analyzer: 3.5K); Favorites (Biolytics: 115; Data Analyzer: 110). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Biolytics vs Data Analyzer monthly traffic comparison, Biolytics currently shows 1.9K visits and Data Analyzer shows 3.5K; Data Analyzer has about 1.9 times the visible traffic of Biolytics, an absolute difference of about 1.7K visits. This reflects visible reach, not feature quality or paid users.
Only Biolytics has complete third-party traffic details; Data Analyzer uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Biolytics and Data Analyzer currently overlap in shared categories: データ管理; shared tags: データ視覚化. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Biolytics's unique categories/tags are 医療、健康とフィットネス、バイオマーカー、血液検査、健康管理、健康追跡、実験レポート、医療データ; Data Analyzer's are 視覚化、ビジネスインテリジェンス、CSV、データ分析、データ探索、Excel、インサイト、瞬時のインサイト. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Biolytics has no verified rating, 0 comments, 115 favorites, and 117 likes;Data Analyzer has no verified rating, 0 comments, 110 favorites, and 107 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Biolytics first
Put Biolytics on the priority trial list when the task aligns with “医療” and especially 医療、健康とフィットネス、バイオマーカー、血液検査、健康管理、健康追跡. This follows recorded positioning and does not imply unlisted capabilities are absent.
Biolytics also currently records: pricing is free, product type is app, 1.9K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Data Analyzer first
Put Data Analyzer on the priority trial list when the task aligns with “視覚化” and especially 視覚化、ビジネスインテリジェンス、CSV、データ分析、データ探索、Excel, or the users include 学術研究者、ビジネスアナリスト、コンサルタント、データアナリスト. This follows recorded positioning and does not imply unlisted capabilities are absent.
Data Analyzer also currently records: pricing is not verified, product type is website, 3.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Biolytics and Data Analyzer, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




